To date, several studies identified FGF-21 as an important player in the pathogenesis of various cardiovascular and metabolic diseases, such as atherosclerosis, coronary heart disease, myocardial infarction, obesity or non-alcoholic fatty liver disease (NAFLD) [13]. This evidence concerns the gene FGF21 and obesity disorder.